parent strain s aureus newman (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
parent strain s aureus newman
Parent Strain S Aureus Newman, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parent+strain+s+aureus+newman/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc07958385-156-11-16
Average 99 stars, based on 1224 article reviews
Parent Strain S Aureus Newman, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parent+strain+s+aureus+newman/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pmc07958385-156-11-16
Average 99 stars, based on 1224 article reviews
parent strain s aureus newman - by Bioz Stars,
2026-09
99/100 stars
Images
1) Product Images from "Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections"
Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections
Journal: Proceedings of the National Academy of Sciences of the United States of America
doi: 10.1073/pnas.2008007118
Figure Legend Snippet: The joint action of bactericidal antibiotics and PYO Sa . Concentrations of the different antibiotics in μg/mL (RIF 0.02, OXA 3, CIP 0.5, VAN 8, DAP 64, KAN 46), corresponding to minimum bacteriocidal concentrations. ( A ) The ratio of the change in density of S. aureus after 24 h of exposure to antibiotics, antibiotics and phage, or phage alone. Hash red, the density of S. aureus recovered was below the detection limit, ∼10 2 per mL. ( B ) The ratio of the change in the density of PYO Sa after 24 h of confronting S. aureus Newman in combination with antibiotics or alone.
Techniques Used:
Related Articles
Bacteria:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Adsorption:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Produced:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Infection:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Drug discovery:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Isolation:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Derivative Assay:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Control:Article Title: Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the Article Title: Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treating Staphylococcus aureus infections Article Snippet: Unless otherwise noted, all experiments were performed from derivatives of the |